Aeterna Zentaris completes $7.8M offering; High-flying startup Moderna gets former Millennium CSO as president of R&D;

@FierceBiotech: From FierceBiotechIT.com: Ex-Yahoo CEO backs genomics big data startup Bina. Article | Follow @FierceBiotech

@JohnCFierce: AstraZeneca commits $815M to partner with FibroGen on anemia drug. News | Follow @JohnCFierce

@RyanMFierce: There are no drugs approved specifically for Fragile X, a top genetic cause of autism and intellectual disability. More | Follow @RyanMFierce

@EmilyMFierce: New compound could combat castration-resistant prostate cancer. Story | Follow @EmilyMFierce

> Aeterna Zentaris ($AEZS) has completed a $7.8 million offering. Release

> The La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin have agreed to extend their longstanding collaboration for another 6 years. Release

> Joseph Bolen has left his gig as chief scientist at Millennium Pharmaceuticals, which recently announced an R&D restructuring, and has joined the high-flying biotech startup Moderna Therapeutics as president of research and development. Release

> Bionomics Limited has made an agreement with Merck ($MRK) to discover and develop novel small molecule candidates for the treatment of chronic pain, including neuropathic pain. Release

Medical Device News

@FierceMedDev: Alere's losses triple as investor fight awaits. Story | Results | Follow @FierceMedDev

@MarkHFierce: Italy's Sorin has finally recovered from earthquake-related earnings challenges. Story | Follow @MarkHFierce

@DamianFierce: Siemens: Löscher's out; Kaeser's in; revenue's still sagging. Much more here: Report | Follow @DamianFierce

> BD joins effort to boost lab quality in China and India. Item

> Qiagen unveils $100M share repurchase plan as income improves. Report

> Trovagene hauls in $15M for diagnostics R&D. Story

Pharma News

@FiercePharma: ICYMI yesterday: Pfizer unit pleads guilty, agrees to pay $491M in off-label marketing case. Report | Follow @FiercePharma

@CarlyHFierce: Rumors swirling about an AstraZeneca Celltrion buyout, but the Korean co. says nothing is definite. Celltrion's statement | Follow @CarlyHFierce

> FDA clears Merck's Januvia, sister meds of new pancreatitis worries. Story

> Sanofi swaps leaders at animal health unit Merial. Item

> Bayer's new drugs shine, fueling 5.5% pharma growth. Article

Drug Delivery News

@MichaelGFierce: Swedish team creates 'impossible' record-breaking drug delivery material. More | Follow @MichaelGFierce

> Mallinckrodt, Depomed win priority review for oral pain med. Report

> Aussie method makes for smaller, more efficient inhaled drugs. More

> DNA-based molecular robots zero in on cancer, autoimmune diseases. Article

> Mercator snags FDA patent for blood-pressure drug delivery catheters. Item

And Finally... A researcher from Maastricht University in the Netherlands has grown the first hamburger from stem cells. The artificial burger will be served next week in London. More

Suggested Articles

The action follows the FDA’s decision to reject a filing for approval of the JAK1 inhibitor in rheumatoid arthritis due to toxicity concerns.

The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.

Drug companies often face steep challenges when entering new markets for the first time. LianBio is here to help.